Skip to main content
BHC logo

BHC · Bausch Health Companies Inc. · Executive Compensation

Track BHC — free
Market Cap
$3.08B
Shares
374.27M
Volume · Nov 20 3.84M Avg daily vol (3M) 3.18M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Thomas J. Appio $16,877,326
Aimee J. Lenar $3,264,491
Fiscal 2024
Executive Total
Thomas J. Appio $16,239,133
Jean-Jaques Charhon $4,267,087
Jean-Jacques Charhon $4,267,087
Seana Carson $3,972,479
Aimee J. Lenar $1,986,437
Fiscal 2023
Executive Total
Thomas J. Appio $15,878,578
Seana Carson $3,157,817
John S. Barresi $1,403,801
Fiscal 2022
Executive Total
Thomas J. Appio $13,171,461
Tom Vadaketh $9,011,699
Robert A. Spurr $4,303,097
Seana Carson $4,212,695
Fiscal 2021
Executive Total
Joseph C. Papa $22,889,137
Thomas J. Appio $10,188,046
Paul S. Herendeen $6,898,849
Christina M. Ackermann $4,574,588
Sam Eldessouky $4,332,224
Robert A. Spurr $3,868,624
Fiscal 2020
Executive Total
Joseph C. Papa $14,119,361
Paul S. Herendeen $5,966,103
Thomas J. Appio $3,828,387
William D. Humphries $3,815,433
Christina M. Ackermann $3,541,028
Sam Eldessouky $1,318,165
Fiscal 2019
Executive Total
Joseph C. Papa $17,141,646
Paul S. Herendeen $6,977,361
Thomas J. Appio $3,958,001
William D. Humphries $3,615,591
Christina M. Ackermann $3,379,932
Fiscal 2018
Executive Total
Joseph C. Papa $14,741,050
Paul S. Herendeen $6,400,807
Thomas J. Appio $4,386,602
Christina M. Ackermann $3,386,907
Ortho Dermatologics $1,374,375
William D. Humphries $1,374,375
Fiscal 2017
Executive Total
Ortho Dermatologics $8,434,206
Joseph C. Papa $4,895,108
Thomas J. Appio $3,429,286
Christina M. Ackermann $2,795,152
Paul S. Herendeen $2,597,950

Executive changes

Person Change Filed
Michael Goettler
“Mr. Goettler’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2026-07-01
Steven D. Miller
“The resignations of Messrs. Icahn and Miller did not result from any disagreement with the Company.”
Resigned 2025-08-15
Brett M. Icahn
“The resignations of Messrs. Icahn and Miller did not result from any disagreement with the Company.”
Resigned 2025-08-15
Sandra Leung Appointed 2025-07-24
Michael Goettler Appointed 2025-07-24
Steven Lee Appointed 2025-07-10
John S. Barresi
“Mr. Barresi’s resignation was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices, including accounting principles, practices and disclosures.”
Resigned 2025-05-15
Aimee Lenar Appointed 2024-07-19
Jean-Jacques Charhon Appointed 2024-07-19
Thomas W. Ross, Sr.
“The retirement of each of Mr. Robertson and Mr. Ross was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the operations, policies or practices of the Company.”
Retired 2024-02-01
Russel C. Robertson
“The retirement of each of Mr. Robertson and Mr. Ross was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the operations, policies or practices of the Company.”
Retired 2024-02-01
Tom Vadaketh
“Mr. Vadaketh's resignation was not because of any disagreement with the Company on any matter relating to the Company's operations, policies or practices, including accounting principles, practices and disclosures.”
Resigned 2023-09-18
Argeris Karabelas
“The retirement of each of Mr. De Schutter and Dr. Karabelas was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the operations, policies or practices of the Company.”
Retired 2023-03-01
Richard De Schutter
“The retirement of each of Mr. De Schutter and Dr. Karabelas was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the operations, policies or practices of the Company.”
Retired 2023-03-01
John A. Paulson Appointed 2022-06-24
Joseph C. Papa
“Mr. Papa’s decision to resign from the Board was not due to any dispute or disagreement with the Company, its management or the Board on any matter relating to the Company’s operations, policies or practices.”
Resigned 2022-06-24
Amy B. Wechsler, M.D. Appointed 2022-06-24
Thomas W. Ross, Sr. Appointed 2022-06-24
Russel C. Robertson Appointed 2022-06-24
Joseph C. Papa Appointed 2022-06-24
Robert N. Power Appointed 2022-06-24
Dr. Richard C. Mulligan Appointed 2022-06-24
Steven D. Miller Appointed 2022-06-24
Dr. Argeris (Jerry) N. Karabelas Appointed 2022-06-24
Sarah B. Kavanagh Appointed 2022-06-24

Leadership

Key facts CIK 885590 CUSIP 071734107 13F (30d) 235 filings 213 filers Visit website Investor relations